Total T-cell and leukemic cell counts in ATL patients before and after alemtuzumab treatment
| Patients . | Total T cells . | Leukemic cells . |
|---|---|---|
| ATL10 (before alemtuzumab) | 52 218 | 46 872 |
| ATL10 (after alemtuzumab) | 427 | 392 |
| ATL11 (before alemtuzumab) | 49 658 | 49 107 |
| ATL11 (after alemtuzumab) | 1136 | 1127 |
| Patients . | Total T cells . | Leukemic cells . |
|---|---|---|
| ATL10 (before alemtuzumab) | 52 218 | 46 872 |
| ATL10 (after alemtuzumab) | 427 | 392 |
| ATL11 (before alemtuzumab) | 49 658 | 49 107 |
| ATL11 (after alemtuzumab) | 1136 | 1127 |